ITCC-063 SELUDEX
A phase IB/II open label study of the MEK-inhibitor selumetinib in combination with dexamethasone for paediatric and adolescent patients with ≥2nd relapsed precursor B or T ALL
Promotor Name : CRTCU
Investigator Name : J. VORMOOR
Trial registered on clinicaltrial.gov: NCT03705507
